🇺🇸 FDA
Pipeline program

MSC

2019-SC-001

Phase 2 small_molecule active

Quick answer

MSC for BPD - Bronchopulmonary Dysplasia is a Phase 2 program (small_molecule) at The Children's Hospital of Zhejiang University School of Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
The Children's Hospital of Zhejiang University School of Medicine
Indication
BPD - Bronchopulmonary Dysplasia
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials